首页> 外文期刊>Heart International >Are there differences in acute phase inflammation markers regarding the type of heart failure?
【24h】

Are there differences in acute phase inflammation markers regarding the type of heart failure?

机译:关于心力衰竭的类型,急性期炎症标志物是否存在差异?

获取原文
           

摘要

This study aimed to determine if there are differences in inflammatory markers in the acute phase between systolic heart failure and heart failure with preserved systolic function. One hundred and thirty-one patients with acute heart failure were recruited consecutively. At admission, plasma fibrinogen, Creactive protein, sialic acid, von Willebrand factor, vascular endothelial growth factor, interleukin-6 and NTproBNP were all evaluated. If the ejection fraction was 45% or over patients were included in the HF-PSF group; the remaining patients were included in the SHF group. The HF-PSF patients were older (72±10 vs 63±12 years, P<0.001), presented a higher rate of atrial fibrillation (56.1 vs 21.3%, P<0.001), and had a lower rate of hemoglobin (12.2±2 vs 13.3±2.1 g/dL, P<0.01). No significant differences were observed in the inflammation markers analyzed among SHF and HFPSF groups. In the acute phase of heart failure there is a marked elevation of inflammatory markers but there are no differences in the inflammatory markers analyzed between the two different types of heart failure
机译:这项研究旨在确定急性期的收缩期心力衰竭和保留了收缩期功能的心力衰竭的炎症标志物是否存在差异。连续招募了131例急性心力衰竭患者。入院时,评估血浆纤维蛋白原,Creactive蛋白,唾液酸,von Willebrand因子,血管内皮生长因子,白介素6和NTproBNP。如果射血分数为45%或以上,则将患者纳入HF-PSF组;其余患者包括在SHF组中。 HF-PSF患者年龄较大(72±10 vs 63±12岁,P <0.001),房颤发生率较高(56.1 vs 21.3%,P <0.001),血红蛋白发生率较低(12.2± 2 vs 13.3±2.1 g / dL,P <0.01)。在SHF和HFPSF组之间分析的炎症指标中未观察到显着差异。在心力衰竭的急性期,炎症标志物明显升高,但两种不同类型的心力衰竭之间分析的炎症标志物没有差异

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号